Wire flash
Baihua Pharmaceutical hits daily limit up, net sell of 313,400 yuan by brokerage seats on dragon and tiger list
Editorial responsibility
- No named human review is recorded for this page.
- Source reporting is collected, normalized, translated or condensed automatically when needed.
- Automatically published source-backed update
Baihua Pharmaceutical (600721) hit its daily price limit on September 22, with a turnover rate of 50.63% and total trading volume of 2.739 billion yuan. According to the Shanghai Stock Exchange's public data, the stock was flagged for a daily price deviation of 9.98% and high turnover. Brokerage departments on the Dragon and Tiger list recorded a net sell of 313.37 million yuan. The top five buy and sell departments combined for 7.03 billion yuan in transactions, with buys at 3.50 billion yuan and sells at 3.53 billion yuan. The largest buy and sell department was Goldman Sachs (China) Securities' Shanghai Pudong Century Avenue branch, with buys of 93.5794 million yuan and sells of 89.0433 million yuan. Over the past six months, the stock has appeared on the Dragon and Tiger list 29 times, with an average gain of 1.19% the next trading day and 2.52% after five days. Main capital saw a net inflow of 204 million yuan on the day, with large orders contributing 185 million yuan. The company's semi-annual report released on August 25 showed revenue of 157 million yuan in the first half, down 22.13% year-on-year, and net profit of 14.7603 million yuan, down 42.08%.
Source report
Baihua Pharmaceutical (600721) hit the daily price limit today, with a turnover rate of 50.63%, total transaction volume of 2.739 billion yuan, and a price amplitude of 8.23%. According to the Dragon and Tiger Board data, brokerage seats recorded a net sell-off of 3.1337 million yuan.
Shanghai Stock Exchange public information shows that the stock was listed on the board due to a daily price deviation of 9.98% and a turnover rate of 50.63%. Brokerage seats collectively recorded a net sell of 3.1337 million yuan.
According to data from Securities Times · Data Bao, the top five buying and selling seats had a total transaction volume of 703 million yuan, with buy-side transactions amounting to 350 million yuan and sell-side transactions reaching 353 million yuan, resulting in a net sell-off of 3.1337 million yuan.
Specifically, both the largest buying and selling seat was Goldman Sachs (China) Securities Co., Ltd., Shanghai Pudong New Area Century Avenue Securities Business Department, with a buy amount of 93.5794 million yuan and a sell amount of 89.0433 million yuan.
Over the past six months, the stock has appeared on the Dragon and Tiger Board 29 times. On average, the stock price rose 1.19% on the next trading day after being listed, and 2.52% within five days after listing.
In terms of capital flow, the stock saw a net inflow of 204 million yuan from main funds today, including 185 million yuan from super-large orders and 18.655 million yuan from large orders. Over the past five days, main funds recorded a net inflow of 725 million yuan.
According to the semi-annual report released by the company on August 25, Baihua Pharmaceutical achieved total operating revenue of 157 million yuan in the first half of the year, a year-on-year decrease of 22.13%, and net profit of 14.7603 million yuan, a year-on-year decline of 42.08%. (Data Bao)
Baihua Pharmaceutical Trading Public Information (September 22)
| Buy/Sell | Member Business Department | Buy Amount (10,000 yuan) | Sell Amount (10,000 yuan) | |---|---|---|---| | Buy 1 | Goldman Sachs (China) Securities Co., Ltd., Shanghai Pudong New Area Century Avenue Securities Business Department | 9,357.94 | | | Buy 2 | Guotai Haitong Securities Co., Ltd. Headquarters | 8,113.86 | | | Buy 3 | Huatai Securities Co., Ltd., Changsha Xiangjiang Middle Road Securities Business Department | 6,600.57 | | | Buy 4 | China International Capital Corporation Limited Shanghai Branch | 5,838.45 | | | Buy 5 | CITIC Securities Co., Ltd., Haining Haichang South Road Securities Business Department | 5,075.84 | | | Sell 1 | Goldman Sachs (China) Securities Co., Ltd., Shanghai Pudong New Area Century Avenue Securities Business Department | | 8,904.33 | | Sell 2 | Guoxin Securities Co., Ltd. Beijing Branch | | 8,665.26 | | Sell 3 | Guotai Haitong Securities Co., Ltd., Beijing Zhichun Road Securities Business Department | | 8,424.72 | | Sell 4 | Guotai Haitong Securities Co., Ltd. Headquarters | | 6,283.38 | | Sell 5 | Guosen Securities Co., Ltd., Zhejiang Internet Branch | | 3,022.35 |
Source
证券之星-证券要闻Neutral / independent